Drug Eluting Balloon
B. Braun – November 2011
Safety and Efficacy: Paclitaxel-Eluting Balloon SeQuent® Please Shows Positive Results in Largest Real World International Registry
The results of the largest registry about treatment with Drug Eluting Balloons (DEB) were presented last week during the Transcatheter Cardiovascular Therapeutics conference (TCT) in San Francisco. Primary investigator Prof. Dr. Jochen Woehrle from the University of Ulm explained: “The aim of the SeQuent Please World Wide Registry is to assess the safety and efficacy of the paclitaxel-coated SeQuent Please treatment of patients under so called real world conditions for multiple indications.” more as PDF Download